Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06162585 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study

Study acronym: REMAIN
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Enrolling by Invitation to Active, Not Recruitingv3
  2. Start date changed from estimate of Dec 2023 to Dec 8, 2023v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will be conducted following Good Clinical Practice (GCP) and International Conference on Harmonization (ICH) guidelines. Eligible subjects will be consented to return for scheduled study visits for this study following their completion in study NTXMCO-002 (RESTORE). They will not receive a second treatment with MCO-010 (or a repeated sham injection) in this study
Trial Details
NCT Number NCT06162585
Lead Sponsor Nanoscope Therapeutics Inc.
Conditions
(from sponsor)		 Retinitis Pigmentosa, Retinitis, Retinal Diseases, Eye Diseases, Eye Diseases, Hereditary, Retinal Dystrophies, Retinal Degeneration
Related terms Eye Diseases, Eye Diseases, Hereditary, Retinal Degeneration, Retinal Diseases, Retinal Dystrophies, Retinitis, Retinitis Pigmentosa, Vision, Low
Enrollment 18 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov